Entering text into the input field will update the search result below

ADMA: Insiders Showing Their Cards

Nov. 02, 2021 6:02 PM ETADMA Biologics, Inc. (ADMA)7 Comments
Jeffrey Himelson profile picture
Jeffrey Himelson


  • ADMA has been trading in a downward trajectory over the past few years.
  • ADMA's stock price has taken a beating from several equity offerings as the business continues to invest in the future.
  • ADMA has positioned itself to perform well and insiders have been putting their money where their mouths are, with recent purchases.
  • This idea was discussed in more depth with members of my private investing community, Invest With A Stacked Deck. Learn More »

Technician at a laboratory surrounded by lab tools

LL28/E+ via Getty Images

It has been painful to be a shareholder of ADMA Biologics (NASDAQ:ADMA) for the past few years. ADMA has financed its growth by issuing numerous equity offerings, which has caused a lot of downward pressure on

ADMA stock chart
Data by YCharts

Invest with a Stacked Deck! Join me to get instant-access to my concentrated portfolio, which includes high-growth and high-yielding components. Given that I make concentrated bets, including those in under-followed opportunities, I will be limiting the total number of subscribers. Start your free two-week trial today before spots fill up

Invest With A Stacked Deck - Marketplace Checkout | Seeking Alpha

This article was written by

Jeffrey Himelson profile picture
Jeffrey Himelson is a corporate lawyer practicing in NYC. He previously worked as a research analyst at a hedge fund and graduated from Columbia Law School in 2017. He is best known on Seeking Alpha for his article "The Trade That Netted Me More Than a 2000% Return."Mr. Himelson is also the author of a book series to teach kids about business: Kimmy and Jimmy's Business Adventures.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ADMA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.